{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:29:36Z","timestamp":1783639776566,"version":"3.55.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"crossref","award":["ZKX21037"],"award-info":[{"award-number":["ZKX21037"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cytomegalovirus (CMV) infection is associated with increased mortality in persons with HIV (PWH). It is less clear whether CMV infection is still associated with mortality when routinely screened and adequately treated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study recruited 1003 hospitalized adults with HIV with CD4 cell counts &amp;lt;200 cells\/\u03bcL from May 2017 to June 2021. Blood CMV DNA was routinely measured and CMV DNAemia was treated if end-organ disease occurred. CMV viral load was categorized into below the limit of quantification (BLQ; &amp;lt;500 IU\/mL), low viral load (LVL; 500\u201310 000 IU\/mL), and high viral load (HVL; \u226510 000 IU\/mL) groups. We compared the 182-day all-cause mortality among different groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median (IQR) CD4 cell count of patients was 33 (13\u201384) cells\/\u03bcL. The prevalence of CMV DNAemia was 39.8% (95% CI: 36.7\u201342.9%) and was significantly associated with CD4 cell count. The 182-day all-cause mortality was 9.9% (95% CI: 8.0\u201311.7%). Univariable analysis showed that, compared with BLQ, LVL and HVL were associated with 1.73-fold and 3.81-fold increased risks of mortality, respectively (P = .032 and P &amp;lt; .001). After adjustment for predefined confounding factors, HVL but not LVL was still associated with increased risk of mortality (adjusted hazard ratio: 2.63; 95% CI: 1.61\u20134.29; P &amp;lt; .001). However, for patients on effective antiretroviral therapy, the impact of HVL on 182-day mortality was not significant (P = .713).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High CMV viral load in hospitalized PWH was associated with higher mortality, even when identified early by screening. Optimalization of the management for those patients needs to be explored in future studies.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciac892","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T22:44:22Z","timestamp":1668206662000},"page":"1266-1275","source":"Crossref","is-referenced-by-count":10,"title":["High Cytomegalovirus Viral Load Is Associated With 182-Day All-Cause Mortality in Hospitalized People With Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"76","author":[{"given":"Mingxia","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Lin","sequence":"additional","affiliation":[{"name":"Center for Global Health, School of Public Health, Nanjing Medical University , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congyue","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Public Health, Nanjing Medical University , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Peng","sequence":"additional","affiliation":[{"name":"School of Public Health, Nanjing Medical University , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine , Nanjing , China"},{"name":"Center for Global Health, School of Public Health, Nanjing Medical University , Nanjing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"2023040319412134300_","author":"Panel on Opportunistic Infections in Adults and Adolescents with HIV"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/QAD.0000000000003238","article-title":"Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy","volume":"36","author":"Levi","year":"2022","journal-title":"AIDS"},{"key":"2023040319412134300_","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1905857","article-title":"High blood cytomegalovirus load suggests cytomegalovirus retinitis in HIV\/AIDS patients: a cross-sectional study","author":"Du","year":"2021","journal-title":"Ocul Immunol Inflamm."},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/QAI.0000000000000410","article-title":"Diagnostic utility of quantitative plasma cytomegalovirus DNA PCR for cytomegalovirus end-organ diseases in patients with HIV-1 infection","volume":"68","author":"Mizushima","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/cit173","article-title":"Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality","volume":"57","author":"Durier","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1468-1293.2010.00900.x","article-title":"Clinical relevance of cytomegalovirus viraemia","volume":"12","author":"Amari EB","year":"2011","journal-title":"HIV Med"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","article-title":"Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy","volume":"363","author":"Deayton","year":"2004","journal-title":"Lancet"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/QAI.0b013e3181a254c2","article-title":"Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004\u20132007)","volume":"51","author":"Micol","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/cid\/ciz864","article-title":"Cytomegalovirus viremia associated with increased mortality in cryptococcal meningitis in sub-Saharan Africa","volume":"71","author":"Skipper","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/cid\/ciab604","article-title":"Cytomegalovirus viremia and clinical outcomes in Kenyan children diagnosed with human immunodeficiency virus (HIV) in hospital","volume":"74","author":"Wamalwa","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcimb.2020.00170","article-title":"Underlying cryptococcal diseases and the correlation with Serum cryptococcal antigen titers in hospitalized HIV-infected patients screened positive for cryptococcal antigenemia","volume":"10","author":"Xu","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2023040319412134300_","first-page":"1","article-title":"Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1743-422X-7-73","article-title":"Monitoring human cytomegalovirus infection with nested PCR: comparison of positive rates in plasma and leukocytes and with quantitative PCR","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"key":"2023040319412134300_","first-page":"1","article-title":"Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged &lt;18 months and for HIV infection and AIDS among children aged 18 months to &lt;13 years\u2014United States, 2008","volume":"57","author":"Schneider","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203437","article-title":"Hospitalization of HIV positive patients in a referral tertiary care hospital in Antananarivo Madagascar, 2010\u20132016: trends, causes and outcome","volume":"13","author":"Raberahona","year":"2018","journal-title":"PLoS One"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"e25428","DOI":"10.1002\/jia2.25428","article-title":"HIV-associated morbidity and mortality in a setting of high ART coverage: prospective surveillance results from a district hospital in Botswana","volume":"22","author":"Barak","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/QAD.0000000000003006","article-title":"Incidence of HIV-positive admission and inpatient mortality in Malawi (2012\u20132019): a population cohort study","volume":"35","author":"Burke","year":"2021","journal-title":"AIDS"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/S2352-3018(21)00329-5","article-title":"Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis","volume":"9","author":"Ford","year":"2022","journal-title":"Lancet HIV"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191944","article-title":"Inpatient mortality rates during an era of increased access to HIV testing and ART: a prospective observational study in Lilongwe, Malawi","volume":"13","author":"Matoga","year":"2018","journal-title":"PLoS One"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/00002030-199510000-00005","article-title":"Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community programs for clinical research on AIDS","volume":"9","author":"Chan","year":"1995","journal-title":"AIDS"},{"key":"2023040319412134300_","doi-asserted-by":"crossref","first-page":"e133960","DOI":"10.1172\/JCI133960","article-title":"CMV viral load kinetics as surrogate endpoints after allogeneic transplantation","volume":"131","author":"Duke","year":"2021","journal-title":"J Clin Invest"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac892\/47763101\/ciac892.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/7\/1266\/49734357\/ciac892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/7\/1266\/49734357\/ciac892.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T18:05:21Z","timestamp":1701367521000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/7\/1266\/6827090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,11,14]]},"published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac892","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,11,14]]}}}